Collegium Pharmaceutical, Inc. COLL Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s operating lease liabilities (current)?
- Collegium Pharmaceutical, Inc. (COLL) reported operating lease liabilities (current) of $1.45M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s operating lease liabilities (current) changed year-over-year?
- Collegium Pharmaceutical, Inc.'s operating lease liabilities (current) increased by 11.1% year-over-year, from $1.3M to $1.45M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s operating lease liabilities (current) has grown at a 14.0% compound annual growth rate (CAGR), from $730K to $1.41M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.